Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Van Biesen

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
Critical Care (London, England)|February 25, 2011
Pro/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?Raymond Vanholder, Wim Van Biesen, Eric Hoste, et al.
Blood Purification|December 20, 2005
Peritoneal dialysis in Europe: an analysis of its rise and fallNorbert Lameire, Patrick Peeters, Raymond Vanholder, et al.
Journal of Nephrology|July 1, 2008
Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest?Wim Van Biesen, Norbert Lameire, Francis Verbeke, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 29, 2005
Improving salt balance in peritoneal dialysis patientsWim Van Biesen, Raymond Vanholder, Nic Veys, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 4, 2014
Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over StudySunny Eloot, Raymond Vanholder, Clement Dequidt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literatureJill Vanmassenhove, Raymond Vanholder, Evi Nagler, et al.
Clinical Kidney Journal|June 9, 2016
The cell cycle biomarkers: promising research, but do not oversell themNorbert Lameire, Jill Vanmassenhove, Wim Van Biesen, et al.
Seminars in Dialysis|November 20, 2002
The role of APD in the improvement of outcomes in an ESRD programWim Van Biesen, Nic Veys, Raymond Vanholder, et al.
BMC Nephrology|October 31, 2018
Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic modelAnneleen Pletinck, Wim Van Biesen, Clement Dequidt, et al.
Clinical Kidney Journal|June 7, 2024
Towards a better uptake of home dialysis in Europe: understanding the present and looking to the futureEdwina A Brown, Giulia Boni Brivio, Wim Van Biesen
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
Critical Care (London, England)|February 25, 2011
Pro/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?Raymond Vanholder, Wim Van Biesen, Eric Hoste, et al.
Blood Purification|December 20, 2005
Peritoneal dialysis in Europe: an analysis of its rise and fallNorbert Lameire, Patrick Peeters, Raymond Vanholder, et al.
Journal of Nephrology|July 1, 2008
Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest?Wim Van Biesen, Norbert Lameire, Francis Verbeke, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 29, 2005
Improving salt balance in peritoneal dialysis patientsWim Van Biesen, Raymond Vanholder, Nic Veys, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 4, 2014
Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over StudySunny Eloot, Raymond Vanholder, Clement Dequidt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literatureJill Vanmassenhove, Raymond Vanholder, Evi Nagler, et al.
Clinical Kidney Journal|June 9, 2016
The cell cycle biomarkers: promising research, but do not oversell themNorbert Lameire, Jill Vanmassenhove, Wim Van Biesen, et al.
Seminars in Dialysis|November 20, 2002
The role of APD in the improvement of outcomes in an ESRD programWim Van Biesen, Nic Veys, Raymond Vanholder, et al.
BMC Nephrology|October 31, 2018
Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic modelAnneleen Pletinck, Wim Van Biesen, Clement Dequidt, et al.
Clinical Kidney Journal|June 7, 2024
Towards a better uptake of home dialysis in Europe: understanding the present and looking to the futureEdwina A Brown, Giulia Boni Brivio, Wim Van Biesen
Pageof 32